THURSDAY, Oct. 17, 2024 (HealthDay News) — An off-label clot-busting drug appears to work slightly better in treating stroke patients than an approved medication, a new review finds. The clot-buster tenecteplase is associated with a slightly higher likelihood of excellent recovery and reduced disability three months following a stroke, comparedContinue Reading

WEDNESDAY, Oct. 16, 2024 (HealthDay News) — Following hurricane damage that shuttered a North Carolina plant that makes 60% of the country’s IV fluids, U.S. health officials have invoked the Defense Production Act to hasten rebuilding of the factory. A nationwide shortage of IV fluids has only worsened since HurricaneContinue Reading

TUESDAY, Oct. 15, 2024 (HealthDay News) — Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. Food and Drug Administration revisits its Oct. 2 decision to remove the medicine from a national drug shortage list. What prompted the FDA to reconsider its decision? On Oct.Continue Reading

MONDAY, Oct. 14, 2024 (HealthDay News) — New findings may worry many parents: Nearly 8 in 10 emergency rooms lack the supplies and training needed to treat pediatric patients, new U.S. research shows. To be ready to address children’s emergencies, ERs need “key pediatric equipment and supplies,” training, policies andContinue Reading